No clinically important difference was demonstrated between paracetamol 3-4 g/day and placebo across all outcomes for knee OA and mixed joint OA (hip/knee). Paracetamol was also found not to be cost-effective due to marginally higher cost of drug acquisition and marginally lower quality adjusted...